🇺🇸 FDA

Intelligence · Patent portfolio

Teva Pharma Patents

Full USPTO pharma patent portfolio for Teva Pharma — grant dates, expiration, and drug cross-links.

Patents
454
Expiring ≤24m
49

Quick answer

Teva Pharma has 454 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 49 expire within 24 months — use filters for patent-cliff planning.

Page 5 of 10

  1. US 8178537

    Solid state forms of varenicline salts and processes for preparation thereof

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8173615

    TRPM-2 antisense therapy

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8163960

    Process for preparing and drying solid rasagiline base

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8158146

    Stable combinations of amlodipine besylate and benazepril hydrochloride

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8148576

    Solid state forms of aliskiren compounds

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8148560

    Vaginal tablets comprising misoprostol and methods of making and using the same

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8124644

    Carvedilol phosphate

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8114900

    Amorphous carvedilol dihydrogen phosphate

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8101712

    Purification processes for echinocandin-type compounds

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8084630

    Process for the synthesis of ramelteon and its intermediates

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8080672

    Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8080584

    Delayed release rasagiline citrate formulation

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8071638

    Solid states of atorvastatin potassium

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8067423

    Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8067473

    Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8063211

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8063250

    Crystal forms of O-desmethylvenlafaxine fumarate

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8048222

    Highly pure modafinil

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8039620

    Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8022190

    Immuno-molecules containing viral proteins, compositions thereof and methods of using

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8022094

    Carvedilol phosphate

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7994178

    Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7989473

    Stable laquinimod preparations

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7977457

    Fusion proteins, uses thereof and processes for producing same

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7973045

    Anhydrous form of dasatinib and process for preparation thereof

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7968749

    Process for preparing and drying solid rasagiline base

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7960586

    Purification of armodafinil

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7928147

    Antimicrobial wash and carrier solutions, and uses thereof

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7923215

    Process for the measurement of the potency of glatiramer acetate

    Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7915412

    Process for the synthesis of 9-hydroxy risperidone (paliperidone)

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7915423

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7910126

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7908729

    Method for making a lollipop

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7884226

    Purification of rosuvatatin intermediate by thin film evaporation and chemical method

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7884208

    Crystals of laquinimod sodium, and process for the manufacture thereof

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7871993

    Tigecycline crystalline forms and processes for preparation thereof

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7867515

    Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7868169

    Crystalline rosuvastatin intermediate

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7858605

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7855233

    Citrate salt of Rasagiline

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7855176

    Reduced volume formulation of glatiramer acetate and methods of administration

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7842717

    DNT-maleate and methods of preparation thereof

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7815942

    Rasagiline formulations of improved content uniformity

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7812168

    Purification of montelukast

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7784616

    Dispenser for progestin used for acute maintenance treatment of DUB

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Teva Pharma have?

454 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

49 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.